Investors Asset Management Of Georgia Inc Gilead Sciences, Inc. Transaction History
Investors Asset Management Of Georgia Inc
- $202 Million
- Q2 2024
A detailed history of Investors Asset Management Of Georgia Inc transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Investors Asset Management Of Georgia Inc holds 18,560 shares of GILD stock, worth $1.56 Million. This represents 0.63% of its overall portfolio holdings.
Number of Shares
18,560
Previous 19,131
2.98%
Holding current value
$1.56 Million
Previous $1.4 Million
9.14%
% of portfolio
0.63%
Previous 0.67%
Shares
25 transactions
Others Institutions Holding GILD
# of Institutions
1,880Shares Held
1.02BCall Options Held
12MPut Options Held
8.96M-
Black Rock Inc. New York, NY121MShares$10.2 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA115MShares$9.7 Billion0.15% of portfolio
-
Capital World Investors Los Angeles, CA76.2MShares$6.42 Billion0.88% of portfolio
-
Capital Research Global Investors Los Angeles, CA60.4MShares$5.09 Billion0.94% of portfolio
-
State Street Corp Boston, MA59.3MShares$4.99 Billion0.18% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $105B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...